Etomoxir‐induced increase in UCP3 supports a role of uncoupling protein 3 as a mitochondrial fatty acid anion exporter
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The physiological function of human uncoupling protein‐3 is still unknown. Uncoupling protein‐ 3 is increased during fasting and high‐fat feeding. In these situations the availability of fatty acids to the mitochondria exceeds the capacity to metabolize fatty acids, suggesting a role for uncoupling protein‐3 in handling of non‐metabolizable fatty acids. To test the hypothesis that uncoupling protein‐3 acts as a mitochondrial exporter of non‐metabolizable fatty acids from the mitochondrial matrix, we gave human subjects Etomoxir (which blocks mitochondrial entry of fatty acids) or placebo in a cross‐over design during a 36‐h stay in a respiration chamber. Etomoxir inhibited 24‐h fat oxidation and fat oxidation during exercise by ~14–19%. Surprisingly, uncoupling protein‐3 content in human vastus lateralis muscle was markedly up‐ regulated within 36 h of Etomoxir administration. Up‐regulation of uncoupling protein‐3 was accompanied by lowered fasting blood glucose and increased translocation of glucose transporter‐4. These data support the hypothesis that the physiological function of uncoupling protein‐3 is to facilitate the outward transport of non‐metabolizable fatty acids from the mitochondrial matrix and thus prevents mitochondria from the potential deleterious effects of high fatty acid levels. In addition our data show that up‐regulation of uncoupling protein‐3 can be beneficial in the treatment of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
Energy metabolism in uncoupling protein 3 gene knockout mice
Vidal-Puig, A. J., Grujic, D., Zhang, C.-Y., Hagen, T., Boss, O., Ido, Y., Szczepanik, A., Wade, J., Mootha, V., Cortright, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910179199 · Cited by 677
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean
Clapham, J. C., Arch, J. R. S., Chapman, H., Haynes, A., Lister, C., Moore, G. B. T., Piercy, V., Carter, S. A., Lehner, I., Smith, S. A., et al. (2000) · Nature · doi:10.1038/35019082 · Cited by 604
Dobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., & McGarry, J. D. (2001) · Diabetes · doi:10.2337/diabetes.50.1.123 · Cited by 315 · cited 1×
“Alternatively, Etomoxir treatment has been shown to increase intramyocellular triglyceride pools in rats (31) and involvement of the muscular triglycerides pools in the up-regulation of UCP3 is well possible.”
BackgroundSCHRAUWEN, P., SARIS, W. H. M., & HESSELINK, M. K. C. (2001) · The FASEB Journal · doi:10.1096/fj.01-0400hyp · Cited by 172 · cited 2×
“Based on the finding that UCP3 content is high in situations in which fatty acid delivery to the muscle exceeds the oxidative capacity, we hypothesized that UCP3 functions as an outward transporter of nonesterified fatty acid anions from the mitochondrial matrix, thereby protecting mitochondria against accumulation of…”
BackgroundSelf-citationUncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes
Schrauwen, P., Hesselink, M. K. C., Blaak, E. E., Borghouts, L. B., Schaart, G., Saris, W. H. M., & Keizer, H. A. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2870 · Cited by 112
Self-citation
Cited by
Martins, A. R., Nachbar, R. T., Gorjao, R., Vinolo, M. A., Festuccia, W. T., Lambertucci, R. H., Cury-Boaventura, M. F., Silveira, L. R., Curi, R., & Hirabara, S. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-30 · Cited by 290
Mitochondrial dysfunction and lipotoxicity
Schrauwen, P., Schrauwen-Hinderling, V., Hoeks, J., & Hesselink, M. K. C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.011 · Cited by 268
High-fat diet, muscular lipotoxicity and insulin resistance
Schrauwen, P. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005277 · Cited by 153
Self-citationMasuda, Y., Haramizu, S., Oki, K., Ohnuki, K., Watanabe, T., Yazawa, S., Kawada, T., Hashizume, S.-I., & Fushiki, T. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00828.2002 · Cited by 143
“It is presently thought to act as a transporter protein of free fatty acid, rather than thermogenesis or energy balance (18, 45).”
BackgroundHuman Uncoupling Protein‐3 and Obesity: An Update
Hesselink, M. K. C., Mensink, M., & Schrauwen, P. (2003) · Obesity Research · doi:10.1038/oby.2003.192 · Cited by 85
Self-citation
Metadata
- Authors
- Schrauwen, P., Hinderling, V., Hesselink, M. K. C., Schaart, G., Kornips, E., Saris, W. H. M., Westerterp‐Plantenga, M., & Langhans, W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-08-21
- Volume
- 16
- Issue
- 12
- Pages
- 1688-1690
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2046374206
- Cited by
- 52
- References
- 6
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Etomoxir‐induced increase in UCP3 supports a role of uncoupling protein 3 as a mitochondrial fatty acid anion exporter. https://app.cochat.ai/papers/10.1096/fj.02-0275fje
- The paper
- Schrauwen, P., Hinderling, V., Hesselink, M. K. C., Schaart, G., Kornips, E., Saris, W. H. M., Westerterp‐Plantenga, M., & Langhans, W. (2002). Etomoxir‐induced increase in UCP3 supports a role of uncoupling protein 3 as a mitochondrial fatty acid anion exporter. The FASEB Journal. https://doi.org/10.1096/fj.02-0275fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.